Back

When to use cardiovascular magnetic resonance in patients receiving chemotherapy?

29 August 2022 (14:18 - 14:36)
Organised by:
Congress Presentation Part of: Meet the Experts: use of multimodality imaging to evaluate cardiotoxicity: when and how? Cross-Modality and Multi-Modality Imaging Topics ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Ana Barac

Inova Health System, Fairfax (United States of America)

3 More presentations in this session

Presentation thumbnail
Role of echocardiography in patients receiving chemotherapy: when and which parameters should be used?
Professor R. Jurcut (Bucharest, RO)
Slides Video
Presentation thumbnail
Computed tomography in patients with late effects of radiotherapy.
Doctor G. Gulati (Oslo, NO)
Slides Video
Presentation thumbnail
Putting it all together: use of multimodality imaging to evaluate cardiotoxicity: when and how?
Professor J. Plana (Philadelphia, US)
Slides Video

Access the full session

Session thumbnail
Meet the Experts: use of multimodality imaging to evaluate cardiotoxicity: when and how?
Video

The Event

Event poster

ESC Congress 2022

29 August 2022 14:18 CET
You may be interested in
thumbnail
Congress Presentation
Role of CMR in contemporary cardio-oncology: where does it fit in?
13 December 2025
thumbnail
Congress Presentation
CMR in immune checkpoint inhibitor-associated myocarditis: do standard CMR diagnostic criteria apply?
13 December 2025
thumbnail
Congress Presentation
CMR in contemporary cardio-oncology - discussion
13 December 2025
thumbnail
Congress Presentation
Cardio-oncology.
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources